Advertisement
Screener

Eledon Pharmaceuticals, Inc. (ELDN) Earnings Per Share, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

Eledon Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted

Eledon Pharmaceuticals, Inc. (ELDN) reported Earnings Per Share, Basic and Diluted of -$0.69 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12

  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.69.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.66.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.50.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.57.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.33.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$15.72.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$24.42.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.56.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 6 month as first filedEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 monthEarnings Per Share, Basic and Diluted 12 month as first filed
2022-03-31-$0.69
10-Q · filed 2022-05-12
2021-12-31-$2.33
10-K · filed 2022-03-24
2021-09-30-$0.66
10-Q · filed 2021-11-12
-$1.73
10-Q · filed 2021-11-12
2021-06-30-$0.50
10-Q · filed 2021-08-12
-$1.07
10-Q · filed 2021-08-12
2021-03-31-$0.57
10-Q · filed 2022-05-12
2020-12-31-$15.72
10-K · filed 2022-03-24
2020-09-30-$5.51
10-Q · filed 2021-11-12
-$16.81
10-Q · filed 2021-11-12
2020-06-30-$2.74
10-Q · filed 2021-08-12
-$0.15
10-Q · filed 2020-08-14
-$11.31
10-Q · filed 2021-08-12
-$0.63
10-Q · filed 2020-08-14
2020-03-31-$8.52
10-Q · filed 2021-05-14
-$0.47
10-Q · filed 2020-05-15
2019-12-31-$24.42
10-K · filed 2021-03-31
-$1.36
10-K · filed 2020-03-17
2019-09-30-$4.01
10-Q · filed 2020-11-16
-$0.22
10-Q · filed 2019-11-13
-$18.74
10-Q · filed 2020-11-16
-$1.04
10-Q · filed 2019-11-13
2019-06-30-$0.35
10-Q · filed 2020-08-14
-$0.85
10-Q · filed 2020-08-14
2019-03-31-$0.52
10-Q · filed 2020-05-15
2018-12-31-$1.56
10-K · filed 2020-03-17
2018-09-30-$0.37
10-Q · filed 2019-11-13
-$1.07
10-Q · filed 2019-11-13
2018-06-30-$0.34
10-Q · filed 2019-08-13
-$0.70
10-Q · filed 2019-08-13
2018-03-31-$0.36
10-Q · filed 2019-05-14
2017-12-31-$2.30
10-K · filed 2019-03-28
2017-09-30-$0.43
10-Q · filed 2018-11-13
-$2.25
10-Q · filed 2018-11-13
2017-06-30-$1.32
10-Q · filed 2018-08-07
-$2.51
10-Q · filed 2018-08-07
2017-03-31-$0.59
10-Q · filed 2018-05-11
-$0.17
10-Q · filed 2017-05-03
2016-12-31-$0.17
10-K · filed 2017-03-03
-$2.46
10-K · filed 2018-04-02
-$1.68
10-K · filed 2017-03-03
2016-09-30-$4.35
10-Q · filed 2017-11-08
-$0.41
10-Q · filed 2016-11-03
-$9.09
10-Q · filed 2017-11-08
-$1.51
10-Q · filed 2016-11-03
2016-06-30-$2.25
10-Q · filed 2017-08-09
-$0.60
10-Q · filed 2016-08-04
-$4.68
10-Q · filed 2017-08-09
-$1.10
10-Q · filed 2016-08-04
2016-03-31-$0.51
10-Q · filed 2017-05-03
2015-12-31-$0.49
10-K · filed 2017-03-03
-$2.01
10-K · filed 2017-03-03
2015-09-30-$0.53
10-K · filed 2017-03-03
-$1.52
10-Q · filed 2016-11-03
2015-06-30-$0.40
10-K · filed 2017-03-03
-$0.99
10-Q · filed 2016-08-04
2015-03-31-$0.59
10-K · filed 2017-03-03
2014-12-31-$0.28
10-K · filed 2016-03-10
-$1.01
derived: net income ÷ weighted average shares · filed 2017-03-03
-$2.18
derived: net income ÷ weighted average shares · filed 2017-03-03
-$3.60
10-K · filed 2017-03-03
2014-09-30-$2.71
10-K · filed 2016-03-10
-$8.57
derived: net income ÷ weighted average shares · filed 2015-11-10
-$15.19
10-Q · filed 2015-11-10
-$23.52
derived: net income ÷ weighted average shares · filed 2016-03-10
2014-06-30-$11.68
10-K · filed 2016-03-10
-$21.48
10-Q · filed 2015-08-12
-$32.69
derived: net income ÷ weighted average shares · filed 2016-03-10
-$39.53
derived: net income ÷ weighted average shares · filed 2016-03-10
2014-03-31-$9.79
10-K · filed 2016-03-10
-$21.00
derived: net income ÷ weighted average shares · filed 2016-03-10
-$27.83
derived: net income ÷ weighted average shares · filed 2016-03-10
2013-12-31-$11.23
10-K · filed 2015-03-26
-$18.04
derived: net income ÷ weighted average shares · filed 2016-03-10
-$38.02
10-K · filed 2016-03-10
2013-09-30-$6.82
10-K · filed 2015-03-26
-$26.36
10-Q · filed 2014-11-13
2013-06-30-$12.95
10-K · filed 2015-03-26
2013-03-31-$7.20
10-K · filed 2015-03-26
2012-12-31-$31.09
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Nkarta, Inc. (NKTX)United States$0.205B-1.73
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12